Change - Announcement of Appointment::Appointment of Independent Director

Issuer & Securities

Issuer/ Manager
TRITECH GROUP LIMITED
Securities
TRITECH GROUP LIMITED - SG2G71000001 - 5G9
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
28-Dec-2023 17:40:14
Status
New
Announcement Sub Title
Appointment of Independent Director
Announcement Reference
SG231228OTHRJY34
Submitted By (Co./ Ind. Name)
Dr Wang Xiaoning
Designation
Managing Director
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr Tan Chade Phang ("Mr Tan") as Independent Director

This announcement has been reviewed by the Company's Sponsor, UOB Kay Hian Private Limited (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01- 01, Singapore 229957, telephone: (65) 6590 6881.

Additional Details

Date Of Appointment
01/01/2024
Name Of Person
Tan Chade Phang
Age
47
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board has accepted the Nominating Committee's recommendation, which has reviewed and considered Mr Tan's qualification and experience, and approved the appointment of Mr Tan as Independent Director of the Company
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director and a member of Audit Committee and Nominating Committee
Professional qualifications
March 2000 to March 2002 - Master of Finance (RMIT University)
January 1998 to January 2000 - Bachelor of Business in Accountancy (RMIT University)
July 1994 to June 1997 - Diploma in Risk and Insurance Management (Nanyang Polytechnic)
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
None
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
November 2015 to Present - President (Small and Middle Capitalization Companies Association)
August 2013 to September 2023 - Chief Executive Officer (Voyage Research Pte. Ltd. (formerly known as SIAS Research Pte. Ltd.))
August 2017 to September 2018 - Director (Bodhi Tree Network Pte. Ltd.)
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
(a) Revez Corporation Ltd.
(b) Camsing Healthcare Limited
(c) TIH Limited
Present
(a) SMI Vantage Limited
(b) Y Ventures Group Ltd.
(c) OUE Healthcare Limited
(d) Luminor Financial Holdings Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
Yes
If Yes, Please provide full details
Appointed as Independent Director of Dapai International Holdings Co. Ltd. in March 2016 and was subsequently appointed as Audit Committee Chairman to oversee the agreed upon procedures (conducted by BDO) and special audit (conducted by KordaMentha) in consultation with SGX on matters prior to the appointment. The findings of the special audit report was released on SGXNet on 7 July 2017.
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
September 2023 to Present - Independent Director (SMI Vantage Limited)
August 2021 to Present - Independent Director (Y Ventures Group Ltd.)
January 2017 to Present - Independent Director (OUE Healthcare Limited)
February 2016 to Present - Independent Director (Luminor Financial Holdings Limited)
February 2021 to March 2023 - Independent Director (Revez Corporation Ltd.)
March 2021 to September 2021 - Independent Director (Camsing Healthcare Limited)
June 2018 to April 2021 - Independent Director (TIH Limited)
September 2019 to October 2020 - Independent Director (TBK and Sons Holdings Limited)
May 2017 to February 2018 - Independent Director (Transcorp Holdings Limited)
March 2016 to July 2018 - Independent Director (Dapai International Holdings Co. Ltd.)
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
N/A